Despite U.S. Food and Drug Administration (FDA) approvals for the addition of anti–programmed death-ligand 1 (PD-L1) therapies to a first-line combination of etoposide plus a platinum-based agent for extensive-stage small […] Read more
Anne Katz, PhD, RN, FAAN, is a certified sexuality counselor and clinical nurse specialist at Cancer Care Manitoba, Winnipeg, Canada, and the author of multiple books on cancer survivorship. In the following article, Dr. Katz discusses lung cancer survivorship challenges as well as considerations that providers should take... Read more
October 2, 2020, saw the first U.S. Food and Drug Administration approval of a drug combination for malignant pleural mesothelioma in 16 years, since the combination cisplatin and pemetrexed was […] Read more
Walter J. “Wally” Curran, Jr., MD, the first radiation oncologist to serve as director of a National Cancer Institute-designated comprehensive cancer center, stepped down from that role at Emory University’s […] Read more
Anne-Marie Dingemans, MD, PhD, was installed in January 2021 as chair of the European Organisation for Research and Treatment of Cancer Lung Cancer Group, filling a role previously held by […] Read more
Marina Chiara Garassino, MD, stepped into a role as professor of medicine in the Section of Hematology/Oncology at the University of Chicago Department of Medicine in March 2021, making a […] Read more
CT screening for lung cancer can reveal subtle early signs of disease in the lungs that extend beyond potential malignancy. As reviewed by Bram van Ginneken, PhD, of the Radboud […] Read more
Although about 20% of those who die of lung cancer in the United States each year have never smoked,1 only individuals with heavy smoking histories are eligible for low-dose CT […] Read more
A wide range of nations at various stages of economic and health-system development fall under the umbrella of low- and middle-income countries (LIMC). As Lucía Viola, MD, of the Fundación […] Read more
Finding one effective test for the three chest conditions that are the leading causes of death in China, without a high risk of false positives, would allow better control of […] Read more